CURANUM AG

EANS-Adhoc: CURANUM AG
Capital Increase Completed

--------------------------------------------------------------------------------
  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
16.11.2012

On November 16, 2012 Curanum AG's capital increase, passed by a resolution of
the Management Board on September 27, 2012 and approved by the Supervisory
Board, was entered in the Commercial Register. Curanum AG's capital stock has
thus increased by EUR3,315,000, from EUR39,132,000 to EUR42,507,000, with
42,507,000 bearer shares each representing a proportionate interest in the
capital stock of EUR1.00 per share. The capital increase has thus been
successfully completed.

The new shares will be issued to subscribers probably by the end of calendar
week 47.

Curanum AG

Munich, November 16, 2012

The Management Board


Further inquiry note:
Frau Caroline Lutz
Unternehmensentwicklung
Tel: 089/ 24 20 65-0
E-Mail: ir@curanum.de

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


issuer:      CURANUM AG
             Engelbertstraße 23-25
             D-81241 München
phone:       +49 (0)89 242065 0
FAX:         +49 (0) 89 242065 10
mail:     ir@curanum.de
WWW:      http://www.curanum.de
sector:      Healthcare Providers
ISIN:        DE0005240709
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Hamburg, Düsseldorf, Stuttgart, regulated
             dealing: München, regulated dealing/prime standard: Frankfurt 
language:   English
 



Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: